新闻中心 - Eurogentec中国区代理商/公司/官网

欢迎来到 Eurogentec中国区代理商/公司/官网

全国咨询热线： 17754422825

Eurogentec中国区代理商/公司/官网

产品中心

推荐产品

invivoCrown IV0107替换BioXCell BE0273

invivoCrown IV0114替换BioXCell BE0213

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：18771997407

传真：15172469628

邮箱：sales@amyjet.com

新闻中心

首页 > 新闻中心

艾美捷科技代理Berry & Associates全系列修饰核苷酸等

美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.

Berry & Associates的主要产品包括：

产品名称	产品编号	纯度	规格
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2'-3'-Dideoxyguanosine	PR 3505	≥95%	25 mg; 100 mg
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
2',3'-Dideoxyuridine	PY 7278	≥97%	100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridine	PY 7279	≥97%	25 mg; 100 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
2-Amino-2'-deoxyadenosine	PR 3060	≥97%	1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine	PR 3080	≥95%	100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosine	PR 3130	≥95%	100 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3670	≥95%	100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine	PR 3070	≥97%	25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine	PR 3160	≥97%	100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate	PR 3180	≥97%	25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3680	≥97%	100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosine	PR 3006	≥95%	25 mg; 100 mg
8-Amino-2'-deoxyadenosine	PR 3115	≥97%	10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosine	PR 3120	≥90%	100 mg; 1 g
8-Azido-2'-deoxyadenosine	PR 3125	≥97%	10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine	PR 3230	≥95%	50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine	PR 3260	≥95%	100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosine	PR 3280	≥97%	100 mg; 1 g
8-Bromo-2'-deoxyadenosine	PR 3290	≥90%	2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3320	≥95%	100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3340	≥97%	0g (discontinued);
2'-Deoxyadenosine Monohydrate	PR 3445	≥97%	25 g; 100 g
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2-Fluoro-2'-deoxyadenosine	PR 3496	≥97%	25 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
N6-Methyl-2'-deoxyadenosine	PR 3740	≥97%	100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine	PRA 10012	≥95%	10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine	PRA 10032	≥95%	10 mg; 50 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosine	PR 3010	≥90%	0Discontinued;
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3015	≥90%	1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3020	≥90%	1 g; 10 g
5'-Azido-5'-deoxyguanosine	PR 3225	≥90%	5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3285	≥90%	1 g; 10 g
8-Bromo-2'-deoxyguanosine	PR 3300	≥90%	1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine	PR 3310	≥97%	500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3330	≥90%	250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine	PR 3335	≥95%	100 mg; 1 g
2'-Deoxyguanosine monohydrate	PR 3452	≥97%	10 g; 100 g
α-2'-Deoxyguanosine	PR 3455	≥97%	10 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine	PR 3600	≥97%	100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosine	PR 3605	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine	PR 3630	≥97%	100 mg; 1 g
N2-Ethyl-2'-deoxyguanosine	PR 3700	≥95%	25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosine	PR 3745	≥97%	10 mg; 100 mg
N1-Methyl-2'-deoxyguanosine	PR 3748	≥97%	25 mg; 1 g
N2-Methyl-2'-deoxyguanosine	PR 3750	≥97%	25 mg; 100 mg
O6-Methyl-2'-deoxyguanosine	PR 3755	≥90%	5 mg; 25 mg
6-Thio-2'-deoxyguanosine	PR 3845	≥97%	10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
2'-O-Methyladenosine	PR 3734	≥97%	1 g;
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridine	PY 7575	≥97%	10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridine	PY 7577	≥97%	10 mg; 100 mg
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine	PR 3000	≥97%	25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine	PR 3200	≥90%	50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosine	PR 3210	≥97%	10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosine	PR 3220	≥97%	10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosine	PR 3240	≥97%	100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine	PR 3250	≥97%	100 mg; 1 g
3'-Deoxyadenosine	PR 3430	≥97%	10 mg; 100 mg
3'-Deoxyguanosine	PR 3460	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine	PR 3590	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosine	PR 3690	≥97%	20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine	PY 7230	≥97%	100 mg;
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3040	≥97%	1 g;
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3045	≥95%	1 g;
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine	PR 3050	≥95%	5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3370	≥97%	100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3380	≥90%	100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine	PR 3390	≥97%	0 g;
6-Chloro-9-(β-D-ribofuranosyl)purine	PR 3400	≥97%	5 g; 10 g
Adenosine	PR 3005	≥97%	100 g; 1 kg
8-Methyladenosine	PR 3007	≥95%	25 mg; 100 mg
Vidarabine	PR 3008	≥97%	1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
N1-Methyladenosine hydroiodide	PR 3032	≥95%	100 mg; 1 g
2-Methyladenosine	PR 3035	≥97%	10 mg; 25 mg
5'-Chloro-5'-deoxyadenosine	PR 3360	≥97%	100 mg; 1 g
N6-Methyladenosine	PR 3732	≥97%	100 mg; 1 g
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10000	≥97%	100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10005	≥97%	500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine	PRA 10006	≥90%	25 mg; 100 mg
8-Azaadenosine	PRA 10007	≥97%	20 mg;
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)	PRA 10008	≥95%	10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine	PRA 10009	≥95%	100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosine	PRA 10010	≥97%	100 mg; 1 g
Allopurinol riboside	PRA 10011	≥97%	25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine	PRA 10020	≥97%	100 mg; 1 g
3-Deaza-2'-deoxyadenosine	PRA 10025	≥97%	25 mg; 100 mg
7-Deaza-2'-deoxyadenosine	PRA 10030	≥97%	100 mg; 1 g
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
7-Deaza-2'-deoxyguanosine	PRA 10040	≥97%	100 mg; 1 g
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
7-Deaza-2'-deoxyxanthosine	PRA 10050	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine	PRA 10055	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
5-Iodotubercidin	PRA 10095	≥90%	5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10100	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10110	≥97%	100 mg; 1 g
Sangivamycin	PRA 10140	≥97%	10 mg; 25 mg
Toyocamycin	PRA 10150	≥97%	10 mg; 100 mg
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
dNaM	FC 8110	≥97%	25 mg; 100 mg
9-Deaza-2'-deoxyguanosine	PRA 10120	≥97%	10 mg; 100 mg
9-Deazaguanosine	PRA 10130	≥97%	10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine	PYA 11000	≥97%	10 mg; 25 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
2'-Deoxypseudoisocytidine	PYA 11005	≥97%	10 mg; 100 mg
2'-Deoxypseudouridine	PYA 11010	Purity: ≥97%	25 mg;
5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine	PYA 11035	Purity: ≥97%	50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridine	PYA 11040	≥97%	10 mg; 100 mg
1,3-Dimethylpseudouridine	PYA 11050	≥97%	10 mg; 50 mg
N1-Methylpseudouridine	PYA 11052	≥95%	10 mg; 50 mg
N3-Methylpseudouridine	PYA 11054	≥97%	10 mg; 25 mg
Showdomycin	PYA 11056	≥97%	10 mg;
Pseudoisocytidine hydrochloride	PYA 11060	≥97%	10 mg; 100 mg
Pseudothymidine	PYA 11070	≥97%	10 mg; 100 mg
Pseudouridine	PYA 11080	≥97%	10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine	PR 3350	≥97%	10 mg;
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-Deoxy-8,5'-cycloadenosine	PR 3440	≥97%	10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosine	PR 3500	≥97%	10 mg;
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine	PR 3730	≥97%	10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosine	PR 3800	≥97%	10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosine	PR 3810	≥97%	10 mg;
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine	PY 7054	≥97%	25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
5-Bromo-2'-deoxycytidine	PY 7115	≥97%	1 g; 10 g
Cytidine	PY 7215	≥97%	50 g; 500 g
2'-Deoxycytidine	PY 7216	≥97%	10 g; 50 g
2'-Deoxycytidine Hydrochloride	PY 7217	≥97%	5 g; 50 g
5'-Azido-2',5'-dideoxycytidine	PY 7219	≥97%	25 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
N4-Ethyl-2'-deoxycytidine	PY 7245	≥97%	100 mg; 250 mg
5-Methyl-2'-deoxyisocytidine	PY 7255	≥95%	500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7270	≥97%	20 mg; 50 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7380	≥97%	50 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine	PY 7410	≥97%	100 mg;
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one	PY 7540	≥95%	250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydrate	PY 7586	≥95%	50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine	PY 7587	≥97%	10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidine	PY 7588	≥97%	50 mg; 100 mg
5-Formyl-2'-deoxycytidine	PY 7589	≥97%	5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidine	PY 7592	≥95%	25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium salt	PY 7593	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxymethylcytidine	PY 7596	≥97%	50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium salt	PY 7598	≥97%	10 mg; 50 mg
5-Formylcytidine	PY 7599	≥97%	5 mg; 10 mg
5-Iodo-2'-deoxycytidine	PY 7607	≥97%	2 g; 10 g
5-Iodocytidine	PY 7609	≥97%	5 g;
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Methyl-2'-deoxycytidine Hydrochloride	PY 7635	≥97%	0.25 g; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methylcytidine	PY 7637	≥97%	1 g; 5 g
N4-Methylcytidine	PY 7638	≥97%	25 mg; 100 mg
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
2-Thiocytidine	PY 7721	≥97%	10 mg; 100 mg
2-Thio-2'-deoxycytidine	PY 7723	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
8-Hydroxyguanosine	PR 3795	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
5-Aza-2'-deoxycytidine	PY 7105	≥95%	25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidine	PY 7106	≥97%	25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
Nap-dU	PY 7735	≥97%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
8-18O-Hydroxyguanosine	IOPR 3795	≥95%	2 mg; 5 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
N2-Dimethylguanosine	PR 3702	≥97%	10 mg; 100 mg
Guanosine	PR 3703	≥97%	100 g; 500 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
O6-Methylguanosine	PR 3757	≥97%	25 mg; 100 mg
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
8-Bromoguanosine	PR 3796	≥97%	0 g;
8-Benzyloxyguanosine	PR 3797	≥95%	100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
2'-Deoxy-4-desmethylwyosine	PR 3450	≥95%	100 mg; 500 mg
2'-Deoxyinosine	PR 3463	≥97%	10 g; 100 g
5'-Azido-2',5'-dideoxyinosine	PR 3464	≥97%	5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosine	PR 3480	≥97%	1 g;
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine	PR 3490	≥90%	1 g;
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine	PR 3660	≥97%	100 mg; 1 g
Inosine	PR 3725	≥97%	100 g; 500 g
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
O6-Phenyl-2'-deoxyinosine	PR 3840	≥97%	100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3842	≥97%	25 mg;
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3843	≥90%	25 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine	PR 3510	≥90%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3520	≥95%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3530	≥90%	100 mg; 1 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
d5SICS	FC 8120	≥97%	25 mg; 100 mg
AICA Riboside (AICAR)	MN 20001	≥97%	0 g (DISCONTINUED);
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine	PR 3692	≥95%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
tC Nucleoside	PYA 11110	≥97%	50 mg; 100 mg
tCnitro Nucleoside	PYA 11115	≥95%	5 mg; 25 mg
2'-Deoxynebularine	PR 3470	Purity: ≥97%	100 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole	PYA 11020	≥97%	50 mg;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole	PYA 11030	≥95%	100 mg;
Showdomycin	PYA 11056	≥97%	10 mg;
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pseudouridine	PYA 11080	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
Toyocamycin	PRA 10150	≥97%	10 mg;
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg;
Allopurinol riboside	PRA 10011	≥97%	25 mg;
5-Iodotubercidin	PRA 10095	≥90%	5 mg;
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg;
5'-Amino-5'-deoxythymidine	PY 7030	≥97%	25 mg; 50 mg
O2,5'-Anhydrothymidine	PY 7060	≥95%	500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
5'-Azido-5'-deoxythymidine	PY 7070	≥97%	25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7120	≥97%	1 g;
3'-O-(t-Butyldimethylsilyl)thymidine	PY 7130	≥95%	500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidine	PY 7140	≥97%	5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidine	PY 7150	≥97%	1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine	PY 7160	≥95%	100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine	PY 7200	≥95%	10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidine	PY 7210	≥95%	10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7250	≥97%	1 g;
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one	PY 7315	≥90%	1 g; 10 g
2',3'-Didehydro-3'-deoxythymidine	PY 7328	≥95%	10 mg; 100 mg
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine	PY 7510	≥97%	50 mg; 100 mg
2-O-Ethylthymidine	PY 7561	≥97%	500 mg; 1 g
5'-Iodo-5'-deoxythymidine	PY 7610	≥97%	250 mg; 1 g
5'-O-Methylthymidine	PY 7680	≥95%	50 mg; 100 mg
2-Thiothymidine	PY 7725	≥95%	20 mg; 100 mg
Thymidine	PY 7727	≥97%	25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidine	PY 7740	≥97%	5 g;
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidine	PY 7750	≥97%	50 mg;
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
6-Azathymidine	PYA 11058	≥95%	25 mg; 100 mg
NPOM-Caged-dT CEP	BA 0317	≥95%	100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
5-Ethynyl uridine CEP	BA 0353	≥90%	100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridine	PY 7053	≥97%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one	PY 7055	≥97%	20 mg; 100 mg
5-Bromo-2'-deoxyuridine	PY 7117	≥97%	10 g; 25 g
5-Bromouridine	PY 7118	≥95%	5 g;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carbomethoxyvinyl)uridine	PY 7172	≥97%	25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridine	PY 7185	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine	PY 7212	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
2'-Deoxyuridine	PY 7275	≥97%	25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine	PY 7280	≥95%	100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7310	≥97%	20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine	PY 7450	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridine	PY 7465	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-Ethynyl-2'-deoxyuridine	PY 7562	≥97%	25 mg; 100 mg
5-Ethynyl uridine	PY 7563	≥97%	10 mg; 100 mg
5-Fluoro-2'-deoxyuridine	PY 7565	≥97%	100 mg; 1 g
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7580	≥97%	25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7590	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridine	PY 7604	≥97%	25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridine	PY 7612	≥95%	100 mg;
5-Iodo-2'-deoxyuridine	PY 7615	≥97%	10 g; 25 g
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
5-Iodouridine	PY 7632	≥95%	5 g; 25 g
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
3-Methyluridine	PY 7694	≥97%	25 mg; 100 mg
5-Methyluridine	PY 7695	≥97%	200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridine	PY 7712	≥95%	10 mg; 100 mg
Zebularine	PY 7715	≥97%	10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine	PY 7720	≥90%	500 mg; 1 g
2-Thiouridine	PY 7724	≥97%	25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine	PY 7730	≥97%	1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine	PY 7758	≥97%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine	PY 7775	≥97%	100 mg; 1 g
Uridine	PY 7780	≥97%	100 g; 500 g
2'3'-O-Isopropylidene uridine	PY 7781	≥97%	5 g; 25 g
5-Hydroxymethyl uridine	PY 7782	≥97%	50 mg; 100 mg
5-Methoxyuridine	PY 7783	≥97%	10 mg; 50 mg
6-Aza-2'-deoxyuridine	PYA 11057	≥95%	50 mg; 100 mg

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

...

阅读详情

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Dendritics"> Dendritics

...

阅读详情

Laysanbio专业提供聚乙二醇类产品，包括多臂聚乙二醇，亲核聚乙二醇，羧基聚乙二醇，亲电型聚乙二醇类，亲电型琥珀酰亚胺基聚乙二醇类，巯基聚乙二醇类。

Laysan Bio, Inc. (Laysan) is a Biotechnology company that offers novel polymers to customers for development of a wide variety of platforms. The management team and key employees have been involved with the development and supply of PEG reagents for seven FDA or EU approved drug products or medical devices including Neulasta®, Somavert®, PEGASYS®, PEG-INTRON®, Definity®, Macugen® and DuraSeal™.

主要产品包括：

Acrylates (ACRL)

Aldehydes (bALD, pALD)

Amines (NH2)

Biotins (BIO)

Carboxylic Acids (COOH, ASA)

Epoxides (EPOX)

Esters (NHS, SAS, SC, SCM, SG, SS, SVA)

Hydrazides (HZ)

Hydroxyls (OH)

Kits of PEG reagents

Maleimides (MAL)

Multi-Arms (4 arm)

Nitrophenyl Carbonates (NPC)

Orthopyridyl Disulfide (OPSS)

Phospholipids (DSPE)

Protected Amines (FMOC, tBOC)

Silane (SIL)

Thiols (SH)

Valeric Acids (VA)

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Laysan Bio"> Laysan Bio

...

阅读详情

艾美捷科技特约代理Axon Medchem产品。

Axon Medchem的业务之一，是独有的Axon Ligands配体库，在世界范围内，被认为是药物研发的标准。这其中，针对850余种生物靶标（包括细胞信号、基因转录、凋亡、细胞周期调控、CNS等），Axon Medchem拥有多达2000余种小分子抑制剂或调节剂。除了配体库，Axon Medchem还是欧洲著名的CRO公司，主要针对生物活性分子和药物类似分子展开合成及协议开发工作，在过去的10年中，Axon Medchem已经发现了多种潜在药物分子，并在生物医药界享有一定的声誉。

Axon Medchem is a trusted supplier of high-value life science products, providing Axon Ligands™ as world wide recognized drug reference standards for pharmacological research. With more than 2000 excellent quality small molecule inhibitors or modulators targeting more than 850 biological targets of cell signaling, gene transcription, apoptosis, cell cycle regulation, CNS and many more areas, Axon Medchem aims to facilitate your scientific research and development.

Axon Medchem is also a leading European CRO in medicinal chemistry, specialized in contract research and high-quality synthesis of bio-active and/or drug-like molecules. We have the proven record in developing novel drug candidates and achieving excellence for a decade by providing our dedicated chemistry services for companies and research institutes active in the field of life sciences around the world.

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Axon Medchem"> Axon Medchem

...

阅读详情

艾美捷科技代理Nanoanalytics品牌全系列产品

nanoAnalytics GmbH创立于1999年，是一家专业从事表面、界面和微观分析领域材料表征的公司，公司的主要产品包括全自动细胞跨膜电阻测量仪（CellZscope）以及cellQART耗材产品。该公司致力于为药物研发、毒理学、基础细胞生物学以及屏障功能研究提供强大的实时、无标记分析工具，以满足科研和工业界对体外细胞屏障模型功能定量评估日益增长的高标准需求。此外，NanoAnalytics公司还提供材料表征服务，运用尖端测量设备，实现微米至纳米量级的材料表面与界面分析。

▍cellZscope产品线

cellZscope®系列是专为非侵入式、自动化测量细胞层跨上皮电阻（TEER）和细胞层电容（Ccl）而设计的先进仪器系统。这些系统能够在模拟体内环境的生理条件下，对生长在多孔膜上的细胞层进行长期、连续且高度自动化的阻抗监测。其技术核心在于利用精密的阻抗分析技术，在尽可能不干扰细胞自然状态的情况下，获取反映细胞层完整性和功能的关键电生理参数。其具有以下特点：

● 提供精确的阻抗读数，兼容广泛使用的标准细胞培养耗材；

● 通过计算机软件实现便捷的数据记录、分析和实验控制；

● 不干扰细胞正常生长环境---测量的数值更加真实；

● 测量采用更宽的频率范围---拟合的数据更加精确；

● 构建的数理模型更加细致---电生理参数更加丰富。

	cZs E	cZs +	cZs 2	cZs 3
Output parameters	TEER	TEER, Ccl	TEER, Ccl	TEER, Ccl
Number of wells	6	24	24	24 (96§)
Supported insert sizes	6-/12-/24-well	6-/12-/24-well	6-/12-/24-well	6-/12-/24-well
Different insert sizes combinable	✔	✔	✔	✔
Works with standard cell culture inserts	✔	✔	✔	✔
Wells / Electrodes autoclavable	✔	✔	✔	✔
Measuring interval adjustable		✔	✔	✔
High-speed measurement			✔	✔
Docking Station			✔	✔
Up to 4 Cell Modules per Controller				✔

▍cellQART产品线

cellQART®是nanoAnalytics公司推出的一套专为配合其核心产品cellZscope®系统使用而设计的高品质、即用型耗材系统。cellQART®提供了多种规格的培养插板（Inserts），兼容标准的多孔板格式，其多孔膜材质（如 PET）和孔径大小经过优化，以满足不同类型细胞培养和精确阻抗测量的需求。

分类	货号	Membrane Optics	Pore Size	Pore Density
24-Well Inserts	932 04 02	translucent	0.4 µm	1×108 /cm2
24-Well Inserts	932 04 12	clear	0.4 µm	2×106 /cm2
24-Well Inserts	932 10 02	translucent	1.0 µm	2×106 /cm2
24-Well Inserts	932 10 12	clear	1.0 µm	2×106 /cm2
24-Well Inserts	932 30 02	translucent	3.0 µm	2×106 /cm2
24-Well Inserts	932 30 12	clear	3.0 µm	0.6×106 /cm2
24-Well Inserts	932 50 02	translucent	5.0 µm	0.6×106 /cm2
24-Well Inserts	932 50 12	clear	5.0 µm	0.6×106 /cm2
24-Well Inserts	932 80 02	translucent	8.0 µm	0.2×106 /cm2
24-Well Inserts	932 80 12	clear	8.0 µm	0.1×106 /cm2
24-Well Inserts	932 04 04	translucent	0.4 µm	1×108 /cm2
24-Well Inserts	932 04 14	clear	0.4 µm	2×106 /cm2
24-Well Inserts	932 10 04	translucent	1.0 µm	2×106 /cm2
24-Well Inserts	932 10 14	clear	1.0 µm	2×106 /cm2
24-Well Inserts	932 04 06	translucent	0.4 µm	1×108 /cm2
24-Well Inserts	932 04 16	clear	0.4 µm	2×106 /cm2
24-Well Inserts	932 10 06	translucent	1.0 µm	2×106 /cm2
24-Well Inserts	932 10 16	clear	1.0 µm	2×106 /cm2
24-Well Inserts	932 00 02	-	-	-
12-Well Inserts	931 04 02	translucent	0.4 µm	1×108 /cm2
12-Well Inserts	931 04 12	clear	0.4 µm	2×106 /cm2
12-Well Inserts	931 10 02	translucent	1.0 µm	2×106 /cm2
12-Well Inserts	931 10 12	clear	1.0 µm	2×106 /cm2
12-Well Inserts	931 30 02	translucent	3.0 µm	2×106 /cm2
12-Well Inserts	931 30 12	clear	3.0 µm	0.6×106 /cm2
12-Well Inserts	931 50 02	translucent	5.0 µm	0.6×106 /cm2
12-Well Inserts	931 50 12	clear	5.0 µm	0.6×106 /cm2
12-Well Inserts	931 80 02	translucent	8.0 µm	0.2×106 /cm2
12-Well Inserts	931 80 12	clear	8.0 µm	0.1×106 /cm2
12-Well Inserts	931 04 04	translucent	0.4 µm	1×108 /cm2
12-Well Inserts	931 04 14	clear	0.4 µm	2×106 /cm2
12-Well Inserts	931 10 04	translucent	1.0 µm	2×106 /cm2
12-Well Inserts	931 10 14	clear	1.0 µm	2×106 /cm2
6-Well Inserts	930 04 02	translucent	0.4 µm	1×108 /cm2
6-Well Inserts	930 04 12	clear	0.4 µm	2×106 /cm2
6-Well Inserts	930 10 02	translucent	1.0 µm	2×106 /cm2
6-Well Inserts	930 10 12	clear	1.0 µm	2×106 /cm2
6-Well Inserts	930 30 02	translucent	3.0 µm	2×106 /cm2
6-Well Inserts	930 30 12	clear	3.0 µm	0.6×106 /cm2
6-Well Inserts	930 50 02	translucent	5.0 µm	0.6×106 /cm2
6-Well Inserts	930 50 12	clear	5.0 µm	0.6×106 /cm2
6-Well Inserts	930 80 02	translucent	8.0 µm	0.2×106 /cm2
6-Well Inserts	930 80 12	clear	8.0 µm	0.1×106 /cm2
6-Well Inserts	930 04 04	translucent	0.4 µm	1×108 /cm2
6-Well Inserts	930 04 14	clear	0.4 µm	2×106 /cm2
6-Well Inserts	930 10 04	translucent	1.0 µm	2×106 /cm2
6-Well Inserts	930 10 14	clear	1.0 µm	2×106 /cm2

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Nanoanalytics品牌全系列产品"> 艾美捷科技代理Nanoanalytics品牌全系列产品

...

阅读详情

艾美捷科技特约代理Atlas Antibodies抗体产品。

Atlas Antibodies公司开发与人类蛋白有关的抗体以及试剂，基于质谱（MS）的定量蛋白质组学，在人体中可能的20,000种蛋白质编码基因中，Atlas已经具有覆盖15,000种的基因产物，超过17,000种抗体，约13,000种蛋白质靶标。

At Atlas Antibodies we have a very clear mission: To provide our customers with advanced research reagents targeting all human proteins. The Human Protein Atlas (HPA) project released the first version of a complete tissue-based map of human protein expression using antibodies in November 2014. In close partnership with the HPA project, we continue to develop advanced antibodies and advanced reagents for Mass Spectrometry (MS)-based quantitative proteomics. Of the possible 20,000 protein coding genes in the human body we already have over 21,000 antibodies covering 15,000 gene products. Learn more in this in the video below.

Atlas Antibodies公司的主要产品包括：

Primary Antibodies

All Primary Antibodies

Triple A Polyclonals

PrecisA Monoclonals

Blocking Antigens

MS Standards

QPrESTs

Laminin Markers

Neuroscience Markers

EMT Markers

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Atlas Antibodies"> Atlas Antibodies

...

阅读详情

DiaMetra公司位于意大利Perugia，致力于为诊断行业提供高品质产品，包括标品和检测试剂盒，涉及的检测领域包括：唾液试剂盒、高血压及钙的代谢、自体免疫疾病、糖尿病指标检测、肿瘤标志物、固醇类激素、性激素、甲状腺激素检测等。

Diametra is dedicated to providing quality products and the highest level of service in its target diagnostics segments. Through innovation and total commitment we strive to create value for our people, our customers and for the shareholders.

As an organization we constantly strive for innovation, not simply in the products we bring to the market but also in the way we interact with our customers and with each other. This is grounded in our solution driven approach to partnership.

产品主要应用领域：

Saliva kits

Hypertension / Calcium Metabolism

Controls

Autoimmune Diseases

Diabetes Monitoring

Tumor Markers

Steroids Hormones

Fertility Proteic Hormones

Thyroid Monitoring

Circulating Immuno Complexes

Miscellaneous

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="DiaMetra"> DiaMetra

...

阅读详情

产品主要应用领域：

Saliva kits

Hypertension / Calcium Metabolism

Controls

Autoimmune Diseases

Diabetes Monitoring

Tumor Markers

Steroids Hormones

Fertility Proteic Hormones

Thyroid Monitoring

Circulating Immuno Complexes

Miscellaneous

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="DiaMetra"> DiaMetra

...

阅读详情

艾美捷科技代理Crystal Positioning Systems (CPS)品牌。

Crystal Positioning Systems (CPS)是专业蛋白结晶设备生厂商，包括：Puck 样品槽、液氮箱、运输箱、样品储存和转移用的工具。Crystal Positioning Systems (CPS) 是一家专注于为X射线晶体学和结构生物学领域提供高精度样品定位和自动化解决方案的公司，CPS 的产品旨在帮助科学家在蛋白质晶体学、材料科学和其他相关领域的研究中，实现更高效、更精确的样品定位和数据收集。公司以其创新的技术、高质量的产品和对客户需求的深刻理解而闻名。核心业务领域：

（1）高精度样品定位系统：CPS 提供用于X射线衍射仪的高精度样品定位系统，支持蛋白质晶体和小分子晶体的精确对准。这些系统能够显著提高数据收集的效率和准确性。

（2）自动化晶体成像系统：公司开发了自动化晶体成像系统，用于实时监测晶体生长过程，帮助科学家优化晶体生长条件。这些系统通常与X射线衍射仪集成，支持从晶体生长到数据收集的全流程自动化。

（3）机器人样品处理系统：CPS 提供机器人样品处理系统，用于高通量晶体筛选和数据收集。这些系统能够自动处理大量样品，显著提高实验效率。

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Crystal Positioning Systems (CPS)品牌"> 艾美捷科技代理Crystal Positioning Systems (CPS)品牌

...

阅读详情

艾美捷科技特约代理EdgeBio公司产品。

EdgeBio公司拥有一批经验丰富的专业研究人员，专注于研发下一代测序技术及应用。

EdgeBio has a team of experienced research professionals that are knowledgeable in next generation sequencing technologies and applications. From library preparation through data analysis, EdgeBio representatives are there to discuss your project on a custom basis to ensure that you receive the results you need for your research.

EdgeBio公司的主要产品包括：

Accessories

Sequencing Clean-Up

PCR Purification

Sample Preparation

Competent Cells

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://eurogentec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="EdgeBio"> EdgeBio

...

阅读详情

16 17 18 19 20 21 22 23 24 25

城市分站

友情链接 invivoCrown IV0121替换BioXCell BE0001-1 invivoCrown IV0112替换BioXCell BE0131 invivoCrown IV0113替换BioXCell BE0075 invivoCrown IV0102替换BioXCell BE0003-1 invivoCrown IV0102替换BioXCell BE0003-1 invivoCrown IV0118替换BioXCell BE0055 invivoCrown IV0106替换BioXCell BE0090 invivoCrown IV0109替换BioXCell BE0164 invivoCrown IV0110替换BioXCell BE0058 invivoCrown IV0100替换BioXCell BE0146

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：18327026838

传真：13212737804

邮箱：sales@amyjet.com

0.3498